(Q41931375)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

0 references

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

author name string

E Skjelbo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

T K Mutabingwa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

K K Nielsen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

L F Gram

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

K Brøosen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

English

0 references

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

304-311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Chloroquine-resistant Plasmodium falciparum malaria in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

A metabolite of paludrine with high antimalarial activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Sparteine and mephenytoin oxidation: genetic polymorphisms in east and west Greenland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

A multifamily study on the relationship between CYP2C19 genotype and S-mephenytoin oxidation phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2980008-7

10.1016/S0009-9236(96)80008-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653993%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference